Cytotoxic CD4+ T cells in viral hepatitis
- 16 June 2006
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 13 (8) , 505-514
- https://doi.org/10.1111/j.1365-2893.2006.00723.x
Abstract
Summary. CD4+ T cells are thought to contribute to antiviral immune responses by secretion of cytokines thereby providing help to CD8+ T and B cells. However, perforin‐positive cytotoxic CD4+ T cells have been described in human immunodeficiency virus‐positive patients suggesting a role not only of CD8+ but also of CD4+ T cells for killing virus‐infected cells. We investigated 76 patients with viral hepatitis [15 hepatitis B virus (HBV), 22 HBV/hepatitis D virus and 17 hepatitis C virus (HCV)] for cytotoxic CD4+ T cells. The frequency of perforin‐positive CD4+ T cells in viral hepatitis was highly variable ranging from + T cells displayed the phenotype of terminally differentiated effector cells (CD28−, CD27−). The highest frequencies of CD4+ cytotoxic T lymphocytes (CTLs) were found in patients with delta hepatitis (P = 0.04 vs HBV and HCV patients), and the presence of CD4+ CTLs was associated with elevated aspartate aminotransferase levels (P = 0.01) and decreased platelet counts (P = 0.03). Perforin‐positive CD4+ T cells decreased in two individuals during spontaneous clearance of acute hepatitis C. Significant associations were found between the frequency of perforin‐expressing CD4+ cells and age (P = 0.04), perforin‐positive CD8+ cells (P < 0.001) and perforin‐positive CD4−/CD8− lymphoid cells (P = 0.002). Differentiated CD27− effector CD4+ CTLs can be detected in patients with viral hepatitis. In particular in patients with more advanced liver disease, the accumulation of perforin‐positive T cells with age could be one correlate for the more severe course of viral hepatitis in elderly individuals.Keywords
This publication has 40 references indexed in Scilit:
- EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B13–14 September, 2002Geneva, SwitzerlandJournal of Hepatology, 2003
- National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002Hepatology, 2002
- Famciclovir treatment of chronic delta hepatitisJournal of Hepatology, 2002
- Escaping High Viral Load ExhaustionThe Journal of Experimental Medicine, 2002
- CD4+CD8dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigensEuropean Journal of Immunology, 2001
- Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoformsEuropean Journal of Immunology, 1999
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Age-related increase in the fraction of CD27−CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiationin vivoClinical and Experimental Immunology, 1994
- Class I and Class Ii Major Histocompatibility Complex Antigen Expression on Hepatocytes: A Study in Children With Liver DiseaseHepatology, 1990
- Individual variation in the frequency of HLA class II‐specific cytotoxic T lymphocyte precursorsEuropean Journal of Immunology, 1990